Brushing your teeth in hospital could reduce the chance of catching pneumonia
You go to the hospital for treatment and to get better. But sometimes, you get something much less welcome: an infection.
12 hours ago
0
5
You go to the hospital for treatment and to get better. But sometimes, you get something much less welcome: an infection.
12 hours ago
0
5
A new study from UTHealth Houston has found that the common sexually transmitted infection Mycoplasma genitalium, also known as MGen, does not appear to increase the risk of recurrent preterm birth. The findings are published ...
3 hours ago
0
1
Risk factors for not initiating a rotavirus vaccine (RVV)—for which the first dose is recommended by a maximum age of 14 weeks, six days—include extremely preterm birth and having no health insurance, according to a study ...
5 hours ago
0
1
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health, or CVD, report encouraging results from an early clinical trial that tested a new dual vaccine against Lassa ...
20 hours ago
0
5
Doing a load of laundry involves lots of decisions—from which cycle to choose to what detergent to use.
6 hours ago
0
0
Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine's key component was designed entirely by AI and has now been ...
13 hours ago
0
2
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.
16 hours ago
0
8
How can we combat the growing global health crisis of antibiotic resistance? At Leiden University, researchers are tackling this issue from multiple angles. Ph.D. candidate Vladyslav Lysenko develops and redesigns new antibiotic ...
14 hours ago
0
2
Growing up witnessing the devastating effects of HIV in her family and community in South Africa pushed Olwam Plaatjie to start using preventive HIV medications three years ago.
21 hours ago
0
2
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health ...